SCHEMBL9457262

SCHEMBL9457262

Cc1nn(CC(O)c2ccc(Cl)cc2)c(=O)n1-c1ccc(N2CCN(c3ccc(O)cc3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 4/20 0.46
TP53 P04637 2/20 0.45
LMNA P02545 2/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
ADRB3 P13945 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
KCNH2 Q12809 1/20 0.42
BRD9 Q9H8M2 1/20 0.42
ME2 P23368 1/20 0.41
ME1 P48163 1/20 0.41
ME3 Q16798 1/20 0.41
CCR1 P32246 1/20 0.40
HTR1A P08908 1/20 0.40
BCHE P06276 1/20 0.39
CHRNE Q04844 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL9457015 0.99 POLB (0.49) POLBKMT2AMAPTTP53LMNA
SCHEMBL8927401 0.90 POLB (0.45) POLBKMT2AMAPTTP53LMNA
SCHEMBL8931753 0.84 L3MBTL1 (0.41) POLBMAPTADRB2ADRB1ADRB3
SCHEMBL9456969 0.81 POLB (0.52) POLBKMT2AMAPTTP53LMNA
SCHEMBL11070469 0.79 BRD9 (0.54) POLBKMT2AMAPTLMNABRD9
SCHEMBL11069372 0.76 MAPT (0.49) POLBKMT2AMAPTLMNABRD9
SCHEMBL9462045 0.75 MAPT (0.45) POLBKMT2AMAPTTP53LMNA
SCHEMBL8927581 0.73 POLB (0.36) POLBKMT2AMAPTTP53LMNA
SCHEMBL11085992 0.73 SMN1; SMN2 (0.49) POLBKMT2AMAPTLMNABRD9
SCHEMBL9457409 0.72 KMT2A (0.66) POLBKMT2AMAPTTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5254553-A 4-[4- [4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-5-methyl-3H-1,2,4-triazol-3-one derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1993-10-19 US disclosed
EP-0532091-A1 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)-phenyl)-5-methyl-3H-1,2,4-triazol-3-one derivatives as 5-lipoxygenase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-17 EP disclosed